drugset / Trial / NCT04029818
Evaluation of a Probiotic on LDL-cholesterol Levels
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the present study is to evaluate the ability of Bifidobacterium BSL\_PS404 in reducing LDL-cholesterol levels in healthy individuals.
Timeline
- Start
- 2019-05-24
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifidobacterium BSL_PS404 | Other / unclassified | 3e+09 cells | Oral |